Cadila Pharmaceuticals: the care continues with Udaipur plant
Cadila Pharmaceuticals is all set to establish a medicinal unit in Udaipur. The pharma giant finally got all the necessary approvals sanctioned by the Chief Minister of the State, Mr. Ashok Gehlot, who headed the State Cabinet Meeting. Cadila Pharmaceuticals will be setting up an Active Pharmaceuticals Ingredients (API) and Manufacturing Unit in the city of lakes, Udaipur.
Cadila Pharmaceuticals will be investing up to Rs 130 crore in the medicinal unit where more than 850 people will get employment opportunity. This opportunity is not limited to the city only, but its people will get more benefits out of it because the unit will attract more opportunities towards it, which will contribute in the development of this rapidly developing City.
The investment is also expected to reach up to Rs 500 Crore in its second phase, but the project will undoubtedly prove fruitful for the local people of Udaipur.
If sources are to be believed, Cadila Pharmaceuticals will also be provided a realisation on the entry tax on some of its capital goods. In order to make this project more successful, Cadila Pharma will be given 70% directive grant and 5% planning grant by the concerned authorities.
The plant might get established in RIICO industrial area of Kaladwas, as 30 acres of land has already been reserved for this purpose. The sources also notified that the Cabinet has additionally approved investment plans worth Rs 8,800 crore for Rajasthan.
Ahmedabad-based Cadila Pharmaceuticals is among largest Pharma companies in the private sector of India, with presence across the 90 countries.
- Previous Heritage Foods Limited targets Rs 6,000 crore turnover by 2020
- Next WWICS offers Cyprus citizenship with an investment program